Patrick J Morris

7PUBLICATIONS
35CO-AUTHORS
Molecular targetsBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 18, 2025
An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors.

Ana Corrionero, Xiaohu Zhang, Patricia Alfonso

|Aug 06, 2025
Discovery and Optimization of LATS1 and LATS2 Kinase Inhibitors for Use in Regenerative Medicine.

Patrick J Morris, Damien Y Duveau, Michele Ceribelli

|Feb 03, 2022
Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2<i>,</i>6)- and (5<i>R</i>)-Methyl-(2<i>R,</i>6<i>R</i>)-hydroxynorketamines.

Jaclyn N Highland, Patrick J Morris, Kylie M Konrath

|Nov 22, 2019
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening.

Grant L Lin, Kelli M Wilson, Michele Ceribelli

|Jul 13, 2018
miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential.

Sara E Meyer, David E Muench, Andrew M Rogers

|Sep 22, 2017
Correction to "Synthesis and N-Methyl-d-aspartate (NMDA) Receptor Activity of Ketamine Metabolites".

Patrick J Morris, Ruin Moaddel, Panos Zanos

Pageof 2

Frequent Collaborators

4 joint publications

Craig J Thomas

2 joint publications

Scott B Hoyt

2 joint publications

Kelli Wilson

1 joint publications

Sara E Meyer